PennyMac Financial Services, Inc. (PFSI) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US70932M1071
PennyMac Financial Services, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 20.11 m USD |
| EBIT | 551.42 m USD |
| Net income | 501.08 m USD |
| Diluted EPS – continuing operations | 9.30 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PennyMac Financial Services, Inc.
PennyMac Financial Services, Inc., through its subsidiaries, engages in the mortgage banking and investment management activities in the United States. The company operates through two segments, Production and Servicing. The Production segment is involved in the origination, acquisition, and sale of loans. This segment also sources residential conventional and government-insured or guaranteed mortgage loans through correspondent production, consumer direct lending, and broker direct lending. The Servicing segment performs loan administration, collection, and default management activities, including the collection and remittance of loan payments; responds to customer inquiries; provides accounting for principal and interest; holds custodial funds for the payment of property taxes and insurance premiums; offers counseling for delinquent borrowers; and supervising foreclosures and property dispositions, as well as administers loss mitigation activities comprising modification and forbearance programs, and supervising foreclosures and property dispositions. The company was founded in 2008 and is headquartered in Westlake Village, California.
More stocks
- GPGI, Inc. (GPGI)
- Syntec Technology Co., Ltd. (7750.TW)
- Shanghai Zhenhua Heavy Industries Co Ltd A (600320.SS)
- GENWORTH FINANCIAL INC (GNW)
- CIE Automotive SA (CIE.MC)
- Optics Technology Holding Co Ltd (300489.SZ)
- CarGurus, Inc. (CARG)
- Kenon Holdings (KEN)
- Kobayashi Pharmaceutical Co Ltd (4967.T)
- Aperam SA (APAM.AS)
- Lisi SA (FII.PA)
- Tate & Lyle PLC (TATE.L)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.